Cargando…
Human-in-the-loop assisted de novo molecular design
A de novo molecular design workflow can be used together with technologies such as reinforcement learning to navigate the chemical space. A bottleneck in the workflow that remains to be solved is how to integrate human feedback in the exploration of the chemical space to optimize molecules. A human...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9795720/ https://www.ncbi.nlm.nih.gov/pubmed/36578043 http://dx.doi.org/10.1186/s13321-022-00667-8 |
_version_ | 1784860322470821888 |
---|---|
author | Sundin, Iiris Voronov, Alexey Xiao, Haoping Papadopoulos, Kostas Bjerrum, Esben Jannik Heinonen, Markus Patronov, Atanas Kaski, Samuel Engkvist, Ola |
author_facet | Sundin, Iiris Voronov, Alexey Xiao, Haoping Papadopoulos, Kostas Bjerrum, Esben Jannik Heinonen, Markus Patronov, Atanas Kaski, Samuel Engkvist, Ola |
author_sort | Sundin, Iiris |
collection | PubMed |
description | A de novo molecular design workflow can be used together with technologies such as reinforcement learning to navigate the chemical space. A bottleneck in the workflow that remains to be solved is how to integrate human feedback in the exploration of the chemical space to optimize molecules. A human drug designer still needs to design the goal, expressed as a scoring function for the molecules that captures the designer’s implicit knowledge about the optimization task. Little support for this task exists and, consequently, a chemist usually resorts to iteratively building the objective function of multi-parameter optimization (MPO) in de novo design. We propose a principled approach to use human-in-the-loop machine learning to help the chemist to adapt the MPO scoring function to better match their goal. An advantage is that the method can learn the scoring function directly from the user’s feedback while they browse the output of the molecule generator, instead of the current manual tuning of the scoring function with trial and error. The proposed method uses a probabilistic model that captures the user’s idea and uncertainty about the scoring function, and it uses active learning to interact with the user. We present two case studies for this: In the first use-case, the parameters of an MPO are learned, and in the second use-case a non-parametric component of the scoring function to capture human domain knowledge is developed. The results show the effectiveness of the methods in two simulated example cases with an oracle, achieving significant improvement in less than 200 feedback queries, for the goals of a high QED score and identifying potent molecules for the DRD2 receptor, respectively. We further demonstrate the performance gains with a medicinal chemist interacting with the system. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13321-022-00667-8. |
format | Online Article Text |
id | pubmed-9795720 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-97957202022-12-29 Human-in-the-loop assisted de novo molecular design Sundin, Iiris Voronov, Alexey Xiao, Haoping Papadopoulos, Kostas Bjerrum, Esben Jannik Heinonen, Markus Patronov, Atanas Kaski, Samuel Engkvist, Ola J Cheminform Research A de novo molecular design workflow can be used together with technologies such as reinforcement learning to navigate the chemical space. A bottleneck in the workflow that remains to be solved is how to integrate human feedback in the exploration of the chemical space to optimize molecules. A human drug designer still needs to design the goal, expressed as a scoring function for the molecules that captures the designer’s implicit knowledge about the optimization task. Little support for this task exists and, consequently, a chemist usually resorts to iteratively building the objective function of multi-parameter optimization (MPO) in de novo design. We propose a principled approach to use human-in-the-loop machine learning to help the chemist to adapt the MPO scoring function to better match their goal. An advantage is that the method can learn the scoring function directly from the user’s feedback while they browse the output of the molecule generator, instead of the current manual tuning of the scoring function with trial and error. The proposed method uses a probabilistic model that captures the user’s idea and uncertainty about the scoring function, and it uses active learning to interact with the user. We present two case studies for this: In the first use-case, the parameters of an MPO are learned, and in the second use-case a non-parametric component of the scoring function to capture human domain knowledge is developed. The results show the effectiveness of the methods in two simulated example cases with an oracle, achieving significant improvement in less than 200 feedback queries, for the goals of a high QED score and identifying potent molecules for the DRD2 receptor, respectively. We further demonstrate the performance gains with a medicinal chemist interacting with the system. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13321-022-00667-8. Springer International Publishing 2022-12-28 /pmc/articles/PMC9795720/ /pubmed/36578043 http://dx.doi.org/10.1186/s13321-022-00667-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Sundin, Iiris Voronov, Alexey Xiao, Haoping Papadopoulos, Kostas Bjerrum, Esben Jannik Heinonen, Markus Patronov, Atanas Kaski, Samuel Engkvist, Ola Human-in-the-loop assisted de novo molecular design |
title | Human-in-the-loop assisted de novo molecular design |
title_full | Human-in-the-loop assisted de novo molecular design |
title_fullStr | Human-in-the-loop assisted de novo molecular design |
title_full_unstemmed | Human-in-the-loop assisted de novo molecular design |
title_short | Human-in-the-loop assisted de novo molecular design |
title_sort | human-in-the-loop assisted de novo molecular design |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9795720/ https://www.ncbi.nlm.nih.gov/pubmed/36578043 http://dx.doi.org/10.1186/s13321-022-00667-8 |
work_keys_str_mv | AT sundiniiris humanintheloopassisteddenovomoleculardesign AT voronovalexey humanintheloopassisteddenovomoleculardesign AT xiaohaoping humanintheloopassisteddenovomoleculardesign AT papadopouloskostas humanintheloopassisteddenovomoleculardesign AT bjerrumesbenjannik humanintheloopassisteddenovomoleculardesign AT heinonenmarkus humanintheloopassisteddenovomoleculardesign AT patronovatanas humanintheloopassisteddenovomoleculardesign AT kaskisamuel humanintheloopassisteddenovomoleculardesign AT engkvistola humanintheloopassisteddenovomoleculardesign |